Celgene Corporation
|
 | ||||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Re: PharmaTimes.com 5Jun2012 Article "Eyebrows raised at ASCO over Abraxane vs paclitaxe study" (150 mg dose in study never used in practice)Who paid for this trial? Celgene-short hedgefunds? Incredible! I would have like to have thought the medical community was a little above such behaviour. But I guess at least some doctors and analysts are not. Deadeyegame
|
|||||||||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 169781 | Re: PharmaTimes.com 5Jun2012 Article "Eyebrows raised at ASCO over Abraxane vs paclitaxe study" (150 mg dose in study never used in practice) | spellchekk | 1 | 6/6/2012 9:29:12 AM |
| 169782 | Deadeye, I believe this trial was sponsored by the National Cancer Institute.... | dogsfriend | 6/6/2012 9:59:18 AM | |
